Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Liquidia Technologies ( (LQDA) ) is now available.
On October 27, 2025, Liquidia Technologies entered into an exclusive licensing agreement with Vectura Limited, granting Liquidia the rights to develop, manufacture, and commercialize products containing treprostinil in the United States using Vectura’s nebulizer device. This agreement involves significant financial commitments, including an upfront payment of $2 million, potential milestone payments up to $104.5 million, and royalty payments. The deal enhances Liquidia’s market positioning in the treatment of pulmonary diseases and provides them with the opportunity to negotiate additional territories and indications in the future.
The most recent analyst rating on (LQDA) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on Liquidia Technologies stock, see the LQDA Stock Forecast page.
Spark’s Take on LQDA Stock
According to Spark, TipRanks’ AI Analyst, LQDA is a Neutral.
Liquidia Technologies’ overall stock score is primarily impacted by its challenging financial performance, with persistent losses and high leverage. The successful launch of YUTREPIA and positive earnings call sentiment provide some optimism, but technical indicators and valuation metrics suggest caution. The company’s ability to navigate market entry challenges and litigation outcomes will be crucial for future performance.
To see Spark’s full report on LQDA stock, click here.
More about Liquidia Technologies
Liquidia Technologies is a subsidiary of Liquidia Corporation, operating in the pharmaceutical industry with a focus on developing treatments for hypertension and interstitial lung diseases, including pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Average Trading Volume: 2,703,479
Technical Sentiment Signal: Buy
Current Market Cap: $1.93B
Learn more about LQDA stock on TipRanks’ Stock Analysis page.